APOC3 and atherosclerosis: These mice are the only genetic rodent model available to our knowledge in which apoC-III targeting does not lower plasma lipid levels, allowing us to study effects of apoC-III atherosclerosis independent of triglyceride lowering, such its effects on inflammation.